Stocks · Health care · Pharmaceutical Preparations

NewAmsterdam Pharma Co N.V.

NAMS Clue Score25
Netherlands Fiscal year ends December CIK 0001936258 Results filed 5 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Louis G Lange
9 Mar 2026
Director
Exercised, kept
44,619
$11.50
$513.12K

What was left out

Form 4 filings counted 28
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 33
Sales at will 6
Transactions with no price 1
Shares from compensation/vesting 2,037,465
History held since 3 Jan 2024